# Limiaoda

Limiaoda develops AI small-molecule drugs, using AI to drive lead discovery and translation. It builds new drug pipelines based on AI, computational chemistry and medicinal chemistry, with a machine-learning lead discovery platform and proprietary optimized underlying algorithms. Its molecular docking platform efficiently screens drugs, shortening compound synthesis and screening, reducing testing and clinical R&D costs, and selecting compounds with stronger activity and better drug-like properties sooner.

Limiaoda develops AI small-molecule drugs, using AI to drive lead discovery and translation. It builds new drug pipelines based on AI, computational chemistry and medicinal chemistry, with a machine-learning lead discovery platform and proprietary optimized underlying algorithms. Its molecular docking platform efficiently screens drugs, shortening compound synthesis and screening, reducing testing and clinical R&D costs, and selecting compounds with stronger activity and better drug-like properties sooner.

Canonical: https://uniquebase.ai/products/limiaoda
Stable identifier: UB-D364
Snapshot captured: 2026-10-15T14:23:27.067Z
English updated: 2026-10-15T23:17:22.427Z

## Connected profiles

- [Leadmuta](/companies/limiaoda)

## Sources

- No source links are available for this profile.